FDA Inspection 1201965 — John A. Phillips, III M.D.
The FDA completed an inspection of John A. Phillips, III M.D. on March 24, 2023 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 24, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional Details
Clinical Investigator (CI)